Proteins / KCTD4

DarkQ8WVF5 · Homo sapiens (Human) · 259 aa

KCTD4

BTB/POZ domain-containing protein KCTD4

AI prediction, not experimentally verified. The function, GO terms and reasoning are generated by a model (BioReason-Pro). Treat them as a hypothesis to test, not as a fact.

Predicted 3D structure

AlphaFold model.

In plain language

KCTD4 has barely been studied. The model's best guess: A soluble cytosolic adaptor that uses an N-terminal oligomerizing scaffold to assemble inhibitory complexes on delayed rectifier potassium channels. By forming multivalent assemblies through its BTB core and a KCTD4-specific C-terminal region, it binds channel cytosolic tails and recruits phosphodiesterases to locally modulate cyclic nucleotide signaling.

Predicted function

A soluble cytosolic adaptor that uses an N-terminal oligomerizing scaffold to assemble inhibitory complexes on delayed rectifier potassium channels.

Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.

Sequence · 259 aa · coloured by model confidence
1MERKINRREK11EKEYEGKHNS21LEDTDQGKNC31KSTLMTLNVG41GYLYITQKQT51LTKYPDTFLE61GIVNGKILCP71FDADGHYFID81RDGLLFRHVL91NFLRNGELLL101PEGFRENQLL111AQEAEFFQLK121GLAEEVKSRW131EKEQLTPRET141TFLEITDNHD151RSQGLRIFCN161APDFISKIKS171RIVLVSKSRL181DGFPEEFSIS191SNIIQFKYFI201KSENGTRLVL211KEDNTFVCTL221ETLKFEAIMM231ALKCGFRLLT241SLDCSKGSIV251HSDALHFIK

Protein domains

Known building blocks found by InterPro, placed along the 259 amino acids of the chain. Hover or tap a block for details.

150100150200259

Predicted function

Model summary

A soluble cytosolic adaptor that uses an N-terminal oligomerizing scaffold to assemble inhibitory complexes on delayed rectifier potassium channels. By forming multivalent assemblies through its BTB core and a KCTD4-specific C-terminal region, it binds channel cytosolic tails and recruits phosphodiesterases to locally modulate cyclic nucleotide signaling. This coordinated binding and scaffolding suppresses channel activity from the cytoplasmic side of the membrane.

Predicted Gene Ontology terms

Molecular function

What it does chemically

Biological process

Which larger process it takes part in

  • GO:1902260 negative regulation of delayed rectifier potassium channel activity

Cellular component

Where in the cell it sits

Model reasoning

How the model got to its answer

  1. 01

    I begin with the InterPro architecture.

    The N-terminal half is dominated by a BTB/POZ scaffold: IPR011333 (SKP1/BTB/POZ domain superfamily, residues 27–135) encompasses a canonical BTB core that is explicitly annotated by IPR000210 (BTB/POZ domain, residues 33–134). Within this core sits IPR003131 (Potassium channel tetramerisation-type BTB domain, residues 36–122), a hallmark that BTB folds in this subfamily are adapted to oligomerize and to engage cytosolic channel tails. This triad establishes an oligomerizing protein–protein interaction module that nucleates higher-order assemblies and recruits partners through avid multivalent binding. The C-terminal half is a lineage-specific tail, IPR045740 (BTB/POZ domain-containing protein KCTD4, C-terminal, residues 138–259), which typically confers target selectivity and regulatory control distinct from the BTB core. The ordered layout—an N-terminal BTB/POZ oligomerization hub followed by a KCTD4-specific C-terminal determinant—creates a soluble adaptor optimized for assembling and modulating cytosolic complexes.

  2. 02

    This BTB-centered architecture dictates molecular function as protein binding (GO:0005515).

    The BTB/POZ fold forms obligate dimers or tetramers and presents composite surfaces that capture cytosolic regions of membrane proteins and signaling enzymes. The potassium channel tetramerisation-type signature (IPR003131) further indicates that the BTB array is tuned to engage and regulate channel assemblies, consistent with a role as a cytosolic adaptor rather than a pore-forming unit.

  3. 03

    From this binding capacity, the biological process emerges.

    A BTB-driven adaptor that recognizes channel cytosolic tails can down-modulate delayed rectifier potassium channels by two convergent mechanisms: first, by sequestering or altering channel tetramers through the potassium-channel-tetramerisation-type interface; second, by recruiting phosphodiesterases via the KCTD4-specific C-terminus to locally reduce cyclic nucleotide levels that influence channel gating. These causal routes align with negative regulation of delayed rectifier potassium channel activity (GO:1902260).

  4. 04

    Cellular location follows from the soluble, oligomerizing architecture and the absence of transmembrane segments: the protein operates in the cytosol (GO:0005829).

    A cytosolic adaptor can approach the inner face of the plasma membrane from the cytoplasmic side, where it assembles inhibitory complexes proximal to channel macromolecular assemblies.

  5. 05

    Mechanistically, I hypothesize that the BTB core oligomerizes to form a multivalent platform that binds delayed rectifier channel subunits and simultaneously recruits cyclic nucleotide–sensing phosphodiesterases.

    The KCTD4-specific C-terminus likely provides docking specificity for these enzymes, thereby coupling channel complexes to local second-messenger turnover. Through this assembly, the adaptor dampens channel activity by stabilizing inhibitory conformations and/or reducing cAMP/cGMP-dependent modulation. Likely interaction partners include delayed rectifier potassium channel cytosolic tails and phosphodiesterases that tune the local signaling milieu.

Technical details

InterPro entries

  • IPR011333 SKP1/BTB/POZ domain superfamily homologous superfamily · 27–135
  • IPR000210 BTB/POZ domain domain · 33–134
  • IPR003131 Potassium channel tetramerisation-type BTB domain domain · 36–122
  • IPR045740 BTB/POZ domain-containing protein KCTD4, C-terminal domain · 138–259

Sources

Method

BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →

API

/api/v1/proteins/Q8WVF5 · API docs